z-logo
Premium
WHIM syndrome: Immunopathogenesis, treatment and cure strategies
Author(s) -
McDermott David H.,
Murphy Philip M.
Publication year - 2019
Publication title -
immunological reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.839
H-Index - 223
eISSN - 1600-065X
pISSN - 0105-2896
DOI - 10.1111/imr.12719
Subject(s) - hypogammaglobulinemia , cxcr4 , immunology , immune system , biology , disease , chemokine receptor , chemokine , immunodeficiency , primary immunodeficiency , medicine , antibody
Summary WHIM syndrome is a rare, autosomal dominant immunodeficiency which is named for the four key manifestations: Warts, Hypogammaglobulinemia, Infections, and Myelokathexis. It results from heterozygous gain‐of‐function mutations in the chemokine receptor CXCR 4 which is widely expressed on leukocytes and has profound influences on immune system homeostasis and organogenesis. New treatments for the disease using drugs to reduce CXCR 4 function are excellent examples of precision medicine. Since CXCR 4 and its ligand CXCL 12 play an important role in a variety of infectious, inflammatory, autoimmune, and malignant diseases, the study of WHIM syndrome provides important insights into both the physiologic and disease roles of these molecules.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here